Geode Capital Management LLC Increases Holdings in Diversified Healthcare Trust (NASDAQ:DHC)

Geode Capital Management LLC boosted its position in Diversified Healthcare Trust (NASDAQ:DHC) by 0.5% in the 4th quarter, Holdings Channel reports. The institutional investor owned 5,696,513 shares of the real estate investment trust’s stock after purchasing an additional 29,062 shares during the period. Geode Capital Management LLC’s holdings in Diversified Healthcare Trust were worth $13,105,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of DHC. Barclays PLC boosted its stake in shares of Diversified Healthcare Trust by 310.2% during the third quarter. Barclays PLC now owns 324,514 shares of the real estate investment trust’s stock valued at $1,360,000 after purchasing an additional 245,405 shares during the period. JPMorgan Chase & Co. grew its holdings in Diversified Healthcare Trust by 60.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 863,806 shares of the real estate investment trust’s stock worth $3,619,000 after acquiring an additional 324,787 shares during the last quarter. SG Americas Securities LLC increased its position in shares of Diversified Healthcare Trust by 55.1% in the fourth quarter. SG Americas Securities LLC now owns 116,782 shares of the real estate investment trust’s stock valued at $269,000 after acquiring an additional 41,489 shares during the period. Inspire Investing LLC raised its stake in shares of Diversified Healthcare Trust by 78.7% during the fourth quarter. Inspire Investing LLC now owns 175,182 shares of the real estate investment trust’s stock valued at $403,000 after acquiring an additional 77,170 shares during the last quarter. Finally, ING Groep NV purchased a new stake in shares of Diversified Healthcare Trust during the fourth quarter worth about $460,000. 75.98% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on DHC. StockNews.com upgraded Diversified Healthcare Trust from a “sell” rating to a “hold” rating in a report on Thursday, April 10th. B. Riley initiated coverage on Diversified Healthcare Trust in a research note on Thursday, April 3rd. They set a “buy” rating and a $4.50 target price on the stock.

Diversified Healthcare Trust Trading Down 0.9 %

NASDAQ:DHC opened at $2.23 on Tuesday. Diversified Healthcare Trust has a 12 month low of $2.00 and a 12 month high of $4.24. The company has a current ratio of 11.57, a quick ratio of 11.57 and a debt-to-equity ratio of 1.44. The company has a 50-day moving average price of $2.47 and a 200-day moving average price of $2.60. The stock has a market cap of $537.96 million, a price-to-earnings ratio of -1.39 and a beta of 2.02.

Diversified Healthcare Trust (NASDAQ:DHC) last posted its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.31. Diversified Healthcare Trust had a negative return on equity of 17.55% and a negative net margin of 26.09%. The business had revenue of $379.62 million for the quarter, compared to analysts’ expectations of $370.97 million.

Diversified Healthcare Trust Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Tuesday, April 22nd will be given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 1.79%. The ex-dividend date is Tuesday, April 22nd. Diversified Healthcare Trust’s dividend payout ratio is currently -2.60%.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.